Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study.

Maria Pia AmatoRoberto BergamaschiDiego CentonzeMassimiliano MirabellaGirolama Alessandra MarfiaRocco TotaroGiacomo LusVincenzo Brescia MorraUmberto AgugliaCristoforo ComiPaola CavallaMauro ZaffaroniMarco RovarisLuigi Maria GrimaldiStefania LeoniSimona MalucchiEleonora BaldiMarcello RomanoMario FalciniPaola PeriniMaurizio AssettaEmilio PortaccioSergio SommacalNunzio OlivieriFranco ParodiDaniele Santo TodaroNicoletta GrassivaroAlberto FarinaMargaret Mary MondinoMassimo FilippiMaria Trojano

Published in: Journal of neurology (2023)

Teriflunomide confirmed its real-world efficacy and was found to have a potentially beneficial effect on cognition.

Keyphrases

disease activity
multiple sclerosis
white matter
rheumatoid arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis
mild cognitive impairment
randomized controlled trial
systematic review